Kerry Hunter
London Health Sciences Centre(CA)
Publications by Year
Research Areas
Diabetes Treatment and Management, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, Neuropeptides and Animal Physiology, Cannabis and Cannabinoid Research
Most-Cited Works
- → Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis(2012)489 cited
- → Effects of the glucagon-like polypeptide-1 analogue (Val8)GLP-1 on learning, progenitor cell proliferation and neurogenesis in the C57B/16 mouse brain(2012)42 cited
- → Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes(2008)41 cited
- → Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice(2008)39 cited
- → Comparison of independent and combined metabolic effects of chronic treatment with ( pGlu ‐Gln)‐ CCK ‐8 and long‐acting GLP ‐1 and GIP mimetics in high fat‐fed mice(2013)35 cited
- → Metabolic effects of sustained activation of the GLP‐1 receptor alone and in combination with background GIP receptor antagonism in high fat–fed mice(2009)34 cited
- → Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice(2008)29 cited
- → Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes(2007)18 cited
- → Characterisation and biological activity of Glu3 amino acid substituted GIP receptor antagonists(2007)15 cited
- → Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice(2008)12 cited